Acorn Capital Advisors, LLC
Annual return '25
+9.6%
SPY '25
+17.7%
Alpha
-8.1ptsvs SPY
Invested
$531.1M
Holdings
22
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 100%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$TERN
TERNS PHARMACEUTICALS INC
Q1 2026: Increased +3.2% (44.5k → 46.0k shares)
26.2%
02
$CGON
CG ONCOLOGY INC
Q1 2026: Sold 5.7% (12.3k → 11.6k shares)
21.8%
03
$URGN
UROGEN PHARMA LTD
Q1 2026: Sold 58.3% (14.0k → 5.8k shares)
8.6%
04
$PBYI
PUMA BIOTECHNOLOGY INC
Held since at least Q1 2024
7.5%
05
$TRVI
TREVI THERAPEUTICS INC
Q1 2026: Increased +13.8% (39.4k → 44.9k shares)
7.3%
06
$CADL
CANDEL THERAPEUTICS INC
Held since at least Q1 2024
4.9%
07
$BCAX
BICARA THERAPEUTICS
Held since at least Q1 2024
3.6%
08
$OKUR
ONKURE THERAPEUTICS INC
Held since at least Q1 2024
3.3%
09
$JBIO
JADE BIOSCEINCES INC
Q1 2026: Sold 99.3% (12.5k → 88 shares)
3.1%
10
$TARA
PROTARA THERAPEUTICS INC
Q1 2026: Exited (was 10.7k shares)
2.6%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 11:17 UTC.